Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv - Bilateral breast cancer and local relapse: a hospital-based study of the prevalence of BRCA 1 and BRCA 2 gene Mutations
Bremer, M.; Steinmann, D.; Dork, T.; Borger, J.; Rades, D.; Karstens, J.H.
Strahlentherapie und Onkologie 177(7): 325-329
2001
ISSN/ISBN: 0179-7158 Document Number: 256264
Document emailed within 1 workday
Related Documents
Triantafyllidou, O.; Vlachos, I.S.; Apostolou, P.; Konstantopoulou, I.; Grivas, A.; Panopoulos, C.; Dimitrakakis, C.; Kassanos, D.; Loghis, C.; Bramis, I.; Vlahos, N.; Yannoukakos, D.; Fostira, F. 2015: Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece Journal of BUON: Official Journal of the Balkan Union of Oncology 20(4): 978-984Levavi, H.; Sabah, G. 2003: BRCA susceptibility genes--a review of current conservative management of BRCA mutation carriers European Journal of Gynaecological Oncology 24(6): 463-466
Grann, V. 1997: Risk of breast cancer in carriers of BRCA gene mutations New England Journal of Medicine 337(11): 788
Olmos, D.; Castro, E. 2013: BRCA mutations in prostate cancer patients Clinical Advances in Hematology and Oncology: H&o 11(9): 598-599
Narod, S.A.; Sun, P.; Risch, H.A. 2001: Ovarian cancer, oral contraceptives, and BRCA mutations New England Journal of Medicine 345(23): 1706-1707
Howard-McNatt, M. 2013: Pros and cons of screening for BRCA mutations North Carolina Medical Journal 74(6): 489-490
Carlson, K.; Chung, A.; Mirocha, J.; Donovan, C.; Estrada, S.; Siegel, E.; Giuliano, A.; Amersi, F. 2018: Menopausal Status and Outcomes of BRCA Mutation Carriers with Breast Cancer American Surgeon 84(10): 1584-1588
Gil, F. 1996: Hereditary breast cancer risk: factors associated with the decision to undergo BRCA 1 testing European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 5(6): 488-490
Ben David, Y.; Chetrit, A.; Hirsh-Yechezkel, G.; Friedman, E.; Beck, B.D.; Beller, U.; Ben-Baruch, G.; Fishman, A.; Levavi, H.; Lubin, F.; Menczer, J.; Piura, B.; Struewing, J.P.; Modan, B. 2002: Effect of BRCA mutations on the length of survival in epithelial ovarian tumors Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(2): 463-466
Hirsh-Yechezkel, G.; Chetrit, A.; Lubin, F.; Friedman, E.; Peretz, T.; Gershoni, R.; Rizel, S.; Struewing, J.P.; Modan, B. 2003: Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel Gynecologic Oncology 89(3): 494-498
Bit-Sava, E.M.; Belogurova, M.B.; Imianitov, E.N.; Balandov, S.G.; Korniushin, O.V.; Borisov, M.K. 2013: Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers Voprosy Onkologii 59(2): 5-11
Oriola, J.; Titos, E.; Leivas, A.; Navarro, M.A.; Rivera-Fillat, F. 1997: Short report on DNA markers at candidate loci. Two new polymorphisms in the BRCA 1 gene Clinical Genetics 51(5): 361-362
Angioni, S.; Pontis, A.; Sorrentino, F.; Nappi, L. 2015: Bilateral salpingo-oophorectomy and adhesiolysis with single port access laparoscopy and use of diode laser in a BRCA carrier European Journal of Gynaecological Oncology 36(4): 479-481
Di Raimo, T.; Angelini, F. 2020: Enhance PARPi Application beyond BRCA-Mutant Breast Cancer (BC): Facts Are Facts Journal of Clinical Medicine 9(8)
Reynolds, T. 2000: NCI-Myriad agreement offers BRCA testing at reduced cost Journal of the National Cancer Institute 92(8): 596
Lubiński, J.; Tarnowska, C.ła.; Jaworowska, E.; Byrski, T.; Jakubowska, A.; Górski, B.; Bień, S.ła.; Sygut, J.; Góźdź, S.ła.; Siołek, M.; Sulikowski, M.ła.; Lubiński, J. 2008: Pleomorphic adenoma of salivary glands does not appear to be a BRCA-1-dependent tumour in a Polish cohort Anticancer Research 28(5b): 3011-3013
Khan, Z.U.; Khan, R.A.; Muhammad, B.; Ullah, H.; Ullah, A.; Ahmed, M. 2018: Prevalence of breast cancer in southern part of KPK Pakistan hospital BINOR based study JPMA. Journal of the Pakistan Medical Association 68(3): 499-500
Murgić, J.; Prpić, M.; Kirac, I.; Camino-Varela, A.-M.; Bolanca, A.; Kusić, Z. 2012: Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer Collegium Antropologicum 36(1): 325-329
Glebov, O.K.; McKenzie, K.E.; White, C.A.; Sukumar, S. 1994: Frequent p53 gene mutations and novel alleles in familial breast cancer Cancer Research 54(14): 3703-3709
Kocic, B.; Petrovic, B.; Filipovic, S. 2008: Risk factors for breast cancer: a hospital-based case-control study Journal of BUON: Official Journal of the Balkan Union of Oncology 13(2): 231-234